Assistant Professor Camilla Gustafsen

Aarhus University Hospital, Aarhus (Denmark)

Follow

Contributor content

SorLA is a novel high affinity PCSK9 receptor that inhibits its inactivation by furin

Presentation

SorLA is a novel high affinity PCSK9 receptor that inhibits its inactivation by furin

ESC 365 is supported by

novartis

Explore sponsored resources